Mexico’s pharma industry eyes growth with 13B pesos promised for drug development and manufacturing

Four Mexican pharmaceutical companies announced concern plans totaling much than 13 cardinal pesos astatine President Claudia Sheinbaum’s Thursday greeting property conference.

Sheinbaum said astatine the commencement of the property league that the 4 companies — Kener, Genbio, Neolpharma and Neolsym — had “decided to articulation Plan México,” the national government’s ambitious economical inaugural that seeks to spur concern and marque Mexico much self-sufficient, among different objectives.

Medication shortages person plagued Mexico’s nationalist wellness strategy successful caller years. Families of children with crab person notably led galore protests, similar this 1 successful 2021. (Daniel Augusto/Cuartoscuro)

The concern announcements travel astatine a clip erstwhile Mexico continues to acquisition long-running shortages of assorted medications, including ones utilized successful the attraction of cancer. The national authorities is aiming to summation home accumulation of medications and aesculapian devices arsenic portion of its Plan México initiative.

“Mexico needs to summation its self-sufficiency … successful everything to bash with medicines,” Economy Minister Marcelo Ebrard said connected Thursday morning.

The CEO of Laboratorios Kener, which makes a assortment of medications including injectable drugs, was the archetypal pharmaceutical enforcement to talk astatine Sheinbaum’s property conference.

“Presidenta, contiguous we privation to proudly denote an concern program of much than 5.18 cardinal pesos [US $277.3 million],” Federico Prince Laris said.

He said that Kener would grow its works successful Toluca, México state, to “triple” its “installed capacity,” and noted that the task was expected to beryllium finished by the archetypal 4th of 2027.

Prince Laris explained that Kener specializes successful “cardiology, hematology and anti-infective products” arsenic good arsenic “emergency medications known arsenic ‘crash cart‘” drugs.

“In caller years, we’ve focused connected the in-hospital injectables segment, which contiguous represents the bosom of our business,” helium said.

Prince Laris said that the 5.18 cardinal peso concern successful Kener’s works volition let the institution to execute a scope of objectives:

• Guarantee “national pharmaceutical sovereignty” successful “several of our products.”
• Create a cause compounding center.
• Offer “comprehensive anesthesia services.”
• Create “new wellness registries for strategical medications for the country.”

Prince Laris said that the concern volition besides let Kener to found a “local accumulation halfway for 3rd procreation CAR T cells,” which are utilized to dainty cancer.

He said the halfway volition beryllium the archetypal of its benignant successful Latin America and “will spot Mexico astatine the forefront of personalized medicine.”

Federico Prince, manager of Kener Laboratories, said the concern volition let Kener to found a section accumulation halfway for modified T-cells utilized successful crab treatment. (Gabriel Monroy/Presidencia)

The CEO said that Kener’s projects volition make astir “800 specialized nonstop jobs” and astir 2,000 indirect ones, “boosting the economical and societal improvement of the country.”

“Presidenta, arsenic you see, our plans are wholly aligned with Plan México,” Prince Laris said.

“… Today, much than ever, pharmaceutical sovereignty is cardinal successful bid to trim dependence connected overseas countries for the proviso of captious medications,” helium said.

Genbio’s 4-billion-peso concern successful a humor plasma plant 

Genbio wide manager José Miguel Ramos Rodríguez noted that the institution helium leads has a “human plasma fractionation plant” successful Chalco, México state. He highlighted that the works is the archetypal of its benignant successful Mexico and each of Latin America.

At the plant, Ramos noted, “we nutrient indispensable medicines specified arsenic albumin, immunoglobulin, and coagulation factors.”

These medicines are “needed by millions of patients” and are indispensable to endurance for immoderate people, arsenic is “the lawsuit for hemophiliacs who request coagulation factors,” helium said.

Genbio plans to grow accumulation of plasma-derived medications astatine its works successful Chalco, México state, manager José Migual Ramos said. (Gabriel Monroy/Presidencia)

Ramos said that Genbio has already invested 2.4 cardinal pesos (US $128.6 million) successful “infrastructure, exertion and talent,” and announced that successful conjunction with Grupo Vazol, a Mexican conglomerate, it volition put an further 1.6 cardinal pesos successful its México authorities plant, creating 100 caller specialized jobs.

The further concern “will let america to summation our capableness to screen adjacent much of the nationalist market,” helium said.

“… Presidenta, convey you precise overmuch for your enactment of the nationalist manufacture and your steadfast committedness to the well-being of patients,” Ramos said.

Neolpharma to put 6 cardinal pesos successful 8 projects 

Luz Astrea Ocampo Gutiérrez de Velasco, wide manager of Grupo Neolpharma, described the institution she leads arsenic “one of the astir important pharmaceutical groups successful the country.”

“We marque everything from vitamins to high-specialty products,” she said.

Ocampo said that the institution is readying to put immoderate 6 cardinal pesos (US $321.5 million) successful coming years to transportation retired 8 projects.

Luz Astrea Ocampo Gutiérrez de Velasco, vice president of Grupo Neolpharma, said her institution is expanding accumulation of vaccines and investing successful cause development. (Gabriel Monroy/Presidencia)

On Thursday morning, she focused connected the 800-million-peso “Alpharma BioGenTec” project, explaining that it is “based connected 2 pillars.”

“One has to bash with infrastructure. The infrastructure volition beryllium for the accumulation of biopharmaceuticals from microbial cells; we volition besides beryllium filling biotechnological products, and we volition besides beryllium making vaccines,” Ocampo said.

“The different limb of the task is [drug] development. As of today, successful this archetypal signifier that we are talking about, we already person 4 bio-generic cause developments,” she said, adding that the institution is collaborating with CICESE, a technological probe halfway successful Baja California, and the Mexico City Ministry of Education, Science, Technology and Innovation.

“But not lone that,” Ocampo said. “We judge successful innovation. Mexico should not lone person innovation, but besides make it. We are moving with nationalist universities connected 2 projects: one, an innovative biotechnological product, and the other, a vaccine.

“Likewise, we are successful talks with prestigious companies astir the satellite that, successful the coming years, volition transportation biotechnology and vaccines to us.”

The Alpharma BioGenTec task is slated to make 110 nonstop and 310 indirect jobs, according to accusation presented by Ocampo.

Neolsym announces 500-million-peso investment 

The enforcement president of Grupo Neolpharma, the genitor institution of Neolsym, announced an concern of 500 cardinal pesos (US $26.8 million) “for the enlargement of our earthy materials accumulation project” successful Ecatepec, México state, and Jiutepec, Morelos.

Neolsym makes progressive pharmaceutical ingredients “that signifier portion of the medications that Mexicans use,” Diego Antonio Gutiérrez de Velasco said.

The 500-million-peso concern is slated to make 120 nonstop jobs and 400 indirect ones.

Neolsym plans to grow accumulation astatine chemic plants successful México authorities and Morelos that nutrient the earthy materials needed to marque a wide assortment of medications utilized successful Mexico. (Daniel Augusto/Cuartoscuro)

Gutiérrez said that presently astir 90% of inputs for medications are imported, and declared that Neolsym, and its genitor institution Neolpharma, are committed to expanding home accumulation “so that we tin person greater power implicit the proviso chain, little costs, and guarantee the availability of medicines.”

“We presently person a works successful the eastbound portion of México state, successful Ecatepec, wherever we are investing successful the improvement of molecules. And we are making a important enlargement successful Jiutepec, Morelos, to motorboat a caller works with the capableness to nutrient high-potency drugs, hormonal drugs,” helium said.

Foreign pharmaceutical concern coming arsenic well, says wellness minister 

The concern announced connected Tuesday by Kener, Genbio, Neolpharma and Neolsym totals 13.28 cardinal pesos (US $712.1 billion). With the 2.4 cardinal pesos Genbio has already invested successful its plasma plant, that magnitude increases to 15.68 cardinal pesos.

Health Minister David Kershenobich said that the 4 Mexican pharmaceutical companies are each supporting Plan México, and asserted that overseas pharmaceutical firms volition arsenic well.

He said that the authorities volition soon denote concern plans of overseas pharmaceutical companies successful Mexico.

“Instead of producing abroad,” specified companies volition “produce successful Mexico,” Kershenobich said.

“… Investment successful the [pharmaceutical] manufacture isn’t conscionable national, but overseas arsenic well, but with accumulation successful the country,” helium said.

In summation to the announcements from these Mexican companies, determination are besides large investments from overseas pharmaceutical companies successful the pipeline, Health Minister Kershenobich said. (Gabriel Monroy/Presidencia)

President Sheinbaum met with Narenda Modi astatine the G7 Summit successful Canada past period and subsequently said that she spoke to the Indian premier curate “about the value of strengthening economical ties betwixt India and Mexico, peculiarly successful immoderate sectors similar the pharmaceutical industry.”

India is simply a large shaper and exporter of pharmaceuticals.

On Tuesday, Kershenobich said that concern successful the pharmaceutical assemblage is not conscionable aimed astatine achieving “health autonomy,” but besides improving “social and wellness well-being” successful Mexico.

“And also, wherefore not accidental it, [there is] an economical payment [as well],” helium said.

Mexico News Daily